Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Placebo (for Motilitone)
Samsung Bioepis NL B.V.
Dyspepsia
1 trial -
Placebo 1 to Probiotic A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Dysfunction
1 trial -
Placebo and Escitalopram
Takeda
Panic Disorder
1 trial -
Placebo plus high-intensity statin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Platelet-rich plasma
COLLEGIUM PHARMACEUTICAL, INC
ACL Injury
1 trial -
Plumpy'Sup
United Therapeutics Europe Ltd
Moderate Acute Malnutrition (MAM)
1 trial -
Polyethylene glycol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonoscopy
1 trial -
Polyethylene glycol (PEG)
Hospital Authority, Hong Kong
Acute Kidney Injury
1 trial -
Polyphenol-rich extract
Atrium Therapeutics
Healthy Elderly
1 trial -
Postoperative radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Tongue Squamous Cell Carcinoma
1 trial -
Power Line Program
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Metabolic Health
1 trial -
Prebiotic Fiber Supplement + loperamide hydrochloride capsule
The First People's Hospital of Lianyungang
Chemotherapy-related Diarrhea
1 trial -
Prebiotics
United Therapeutics Europe Ltd
Prebiotics
1 trial -
Prebiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial -
Prediction Model Arm
The First People's Hospital of Lianyungang
Lung Cancer Screening
1 trial -
Prediction of intraoperative hypothermia risk
The First People's Hospital of Lianyungang
Intraoperative Hypothermia
1 trial -
Prednisolone
The First People's Hospital of Lianyungang
HIV (Human Immunodeficiency Virus)
1 trial -
Prednisolone and/or AZA/MMF
United Therapeutics Europe Ltd
Lupus Nephritis
1 trial -
Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Undifferentiated Connective Tissue Disease
1 trial -
Pregabalin
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
1 trial -
Pregabalin capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia
1 trial -
Preoperative Genotyping
BRIGHT MINDS BIOSCIENCES INC.
PPAP
1 trial -
Preoperative three-dimensional reconstruction
Universal Integrated
Kidney Neoplasms / Surgery
1 trial -
Prepackaged Low-Residue Diet
Universal Integrated
Bowel Preparation Solution
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources